ARTIVION INC

Artivion’s 4.67% rally fuels anticipation for Q3 earnings, revealing a strong aortic‑disease portfolio and a bullish outlook in a volatile market.

Explore Artivion’s upside potential: a solid medical‑device stock trading below its 52‑week low, with new aortic solutions and a strong growth pipeline.

Artivion (AORT) climbs 3.64 % to $22.90, surpassing its 200‑day SMA, showing steady mid‑cap gains amid broader market shifts.